SELLAS Life Sciences Group, Inc. SLS Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s total liabilities?
- SELLAS Life Sciences Group, Inc. (SLS) reported total liabilities of $6.77M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s total liabilities changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s total liabilities decreased by 6.0% year-over-year, from $7.2M to $6.77M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s total liabilities has grown at a -16.2% compound annual growth rate (CAGR), from $18.09M to $7.47M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.